Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Koa Shoji Holdings CoTSE:9273 +0.26%82 3-Year ROIIC % is 33.03 as of Jun. 2026, which is 37% below its 10-year median of 52.81. GuruFocus rates TSE:9273 with a GF Score™ of 82/100 and a GF Value™ of 円751.26 (Fairly Valued). The stock has 1 warning sign investors should review. Among 944 Drug Manufacturers companies, Koa Shoji Holdings Co ranks better than 77.44% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Koa Shoji Holdings Co's 3-Year ROIIC % for the quarter that ended in Jun. 2026 was 33.03%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Koa Shoji Holdings Co's 3-Year ROIIC % or its related term are showing as below:
TSE:9273's 3-Year ROIIC % is ranked better than 77.44% of 944
companies
in the Drug Manufacturers industry
Industry Median: 3.56
vs TSE:9273: 33.03
Koa Shoji Holdings Co (TSE:9273) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Koa Shoji Holdings Co 3-Year ROIIC % Related Terms
Koa Shoji Holdings Co 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Koa Shoji Holdings Co's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Koa Shoji Holdings Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koa Shoji Holdings Co 3-Year ROIIC % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Koa Shoji Holdings Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Koa Shoji Holdings Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Koa Shoji Holdings Co (TSE:9273) has a 3-Year ROIIC % of 33.03 as of Jun. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Koa Shoji Holdings Co and its competitors. This is 37% below median its historical median of 52.81. According to the industry distribution chart, Koa Shoji Holdings Co ranks #213 out of 944 companies in the Drug Manufacturers industry, placing it in the top 22.6%.
Is Koa Shoji Holdings Co's 3-Year ROIIC % too high?
Koa Shoji Holdings Co's current 3-Year ROIIC % of 33.03 is 37% below median its 10-year median of 52.81. The Drug Manufacturers industry median 3-Year ROIIC % is 3.56. Koa Shoji Holdings Co's value of 33.03 is 827.8% above this industry median. Based on the distribution chart, Koa Shoji Holdings Co ranks #213 out of 944 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Koa Shoji Holdings Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koa Shoji Holdings Co's 3-Year ROIIC % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Koa Shoji Holdings Co ranks #213 out of 944 companies for 3-Year ROIIC %. This places Koa Shoji Holdings Co in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.56. Koa Shoji Holdings Co's value of 33.03 is 827.8% above this benchmark. While the company's 10-year median is 52.81 vs. the industry median of 3.56, Koa Shoji Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Drug Manufacturers company?
The median 3-Year ROIIC % among Drug Manufacturers companies is 3.56, based on 944 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koa Shoji Holdings Co's current 3-Year ROIIC % of 33.03 is 827.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Koa Shoji Holdings Co and its competitors. For the Drug Manufacturers industry, the median 3-Year ROIIC % is 3.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koa Shoji Holdings Co's current 3-Year ROIIC % is 33.03, which is 37% below median its own 10-year median of 52.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koa Shoji Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Koa Shoji Holdings Co (TSE:9273) is currently considered Fairly Valued. The stock's GF Value™ is 円751.26, compared to a current price of 円782.00 — trading 4.1% above its estimated fair value. The current 3-Year ROIIC % is 33.03, which is 37% below median its 10-year median of 52.81 and 827.8% above the Drug Manufacturers industry median of 3.56. Koa Shoji Holdings Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Koa Shoji Holdings Co (TSE:9273), the current 3-Year ROIIC % is 33.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koa Shoji Holdings Co (TSE:9273) Overvalued in 2026?
Based on GuruFocus' analysis, Koa Shoji Holdings Co stock appears to be overvalued.
The current stock price of 円782.00 is trading 4.1% above its estimated GF Value™ of 円751.26.
GuruFocus considers Koa Shoji Holdings Co to be Fairly Valued.
Key valuation signals for TSE:9273:
3-Year ROIIC %: 33.03 (37% below median its 10-year median of 52.81)
GF Value™: 円751.26 vs. price of 円782.00 (4.1% above fair value)
Industry Position: 827.8% above the Drug Manufacturers median (#213 of 944)
No single metric tells the full story. See the TSE:9273 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koa Shoji Holdings Co Ltd is a pharmaceutical manufacturing company. It is mainly engaged in the manufacturing, sales, and import/export of pharmaceuticals.
82GF Score
Get the complete analysis for TSE:9273
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9273 has been successfully added to your 
